![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/UNICHEMLAB.png)
Share the post "UNICHEM LABORATORIES ‘s Q3 2024-25 Latest News: Revenue Grows by 22.72% YoY"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 22.72 % in the past year, substantial increase in net sales/revenue by 15.35 %. 🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -82.82 %, Marginal increase in other income during this quarter, up by 54.95%. 🔹 Profit over the Year and quarter: Challenges in sustaining profitability for UNICHEM LABORATORIES LTD.. Profit dropped by -31.12 % Year to Year, UNICHEM LABORATORIES LTD.’s profitability increased by 89.73 % in this quarter. 🔹 EPS over the Year and quarter: EPS declined by -31.10 % Year to Year. EPS increased by 89.4 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 434.379 Cr | Rs. 462.16 Cr | Rs. 533.09 Cr | + 15.35 % | + 22.72 % |
| Expenses | Rs. 396.26 Cr | Rs. 404.63 Cr | Rs. 447.57 Cr | + 10.61 % | + 12.95 % |
| Operating Profit | Rs. 38.12 Cr | Rs. 57.53 Cr | Rs. 85.52 Cr | + 48.65 % | + 124.34 % |
| OPM % | 8.78 % | 12.45 % | 16.04 % | + 3.59 % | + 7.26 % |
| Other Income | Rs. 79.292 Cr | Rs. 8.79 Cr | Rs. 13.62 Cr | + 54.95 % | -82.82 % |
| Interest | Rs. 5.58 Cr | Rs. 4.79 Cr | Rs. 6.75 Cr | + 40.92 % | + 20.97 % |
| Depreciation | Rs. 27.86 Cr | Rs. 28.54 Cr | Rs. 30.54 Cr | + 7.01 % | + 9.62 % |
| Profit before tax | Rs. 83.97 Cr | Rs. 32.99 Cr | Rs. 61.85 Cr | + 87.48 % | -26.34 % |
| Tax % | 0.03 % | 7.58 % | 6.47 % | -1.11 % | + 6.44 % |
| Net Profit | Rs. 83.99 Cr | Rs. 30.49 Cr | Rs. 57.85 Cr | + 89.73 % | -31.12 % |
| EPS in Rs | Rs. 11.92 | Rs. 4.32 | Rs. 8.19 | + 89.58 % | -31.29 % |
Today, we’re looking at UNICHEM LABORATORIES LTD.’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 22.72 %. However, it did see a marginal increase of 15.35 % from the previous quarter. Expenses ticked up slightly by 10.61 % quarter-on-quarter, aligning with the annual rise of 12.95 %. Operating profit, while up 124.34 % compared to last year, faced a quarter-on-quarter increase of 48.65 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 7.26 %, but an expansion of 3.59 % sequentially. Other income rose by 54.95 % compared to the last quarter, despite an annual decline of -82.82 %. Interest expenses surged remarkably by 40.92 % from the previous quarter, yet the year-over-year increase remains at a moderate 20.97 %. Depreciation costs climbed by 7.01 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 9.62 %. Profit before tax declined annually by -26.34 % but saw an increase from the preceding quarter by 87.48 %.
Tax expenses as a percentage of profits increased slightly by 6.44 % compared to last year, with a more notable quarter-on-quarter decrease of -1.11 %. Net profit fell by -31.12 % year-on-year but experienced a 89.73 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -31.29 % but a quarterly rise of 89.58 %. In summary, UNICHEM LABORATORIES LTD.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 434.379 Cr | Rs. 462.16 Cr | Rs. 533.09 Cr | + 15.35 % | + 22.72 % |
| Expenses | Rs. 396.26 Cr | Rs. 404.63 Cr | Rs. 447.57 Cr | + 10.61 % | + 12.95 % |
| Operating Profit | Rs. 38.12 Cr | Rs. 57.53 Cr | Rs. 85.52 Cr | + 48.65 % | + 124.34 % |
| Net Profit | Rs. 83.99 Cr | Rs. 30.49 Cr | Rs. 57.85 Cr | + 89.73 % | -31.12 % |
| EPS in Rs | Rs. 11.92 | Rs. 4.32 | Rs. 8.19 | + 89.58 % | -31.29 % |
In reviewing UNICHEM LABORATORIES LTD.’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 22.72 % year-on-year growth, however, there was a minor increase of 15.35 % from the previous quarter. Expenses rose by 12.95 % compared to the previous year, with a 10.61 % increase quarter-on-quarter. Operating Profit surged by 124.34 % annually, and saw a 48.65 % increase from the last quarter.
Net Profit showed yearly decrease of -31.12 %, and experienced a 89.73 % increase from the previous quarter. Earnings Per Share (EPS) fell by -31.29 % annually, however rose by 89.58 % compared to the last quarter. In essence, while UNICHEM LABORATORIES LTD. faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/HATSUN.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/APLLTD.png)